BABY - Else Nutrition targets FDA approval as it eyes news markets for its plant-based infant nutrition
(NewsDirect)
Else Nutrition CEO Hamutal Cohen Yitzhaktells Proactive's Stephen Gunnion that a number of catalyst lieahead for the company this year, including the launch of its'ready-to-drink' infant nutrition in the US, its entry to theUK market as a starting point for Europe and Australia as a gateway toChina.
Importantly, she said the company remains on track tobegin its infant growth clinical study for the FDA and Europeanpermits. Receiving FDA approval is a very high priority for ElseNutrition, as it believes that becoming the first non-dairy andnon-soy FDA-approved infant formula will be transformational. Yitzhakalso commented on Else's first-quarter results, which showed an80% year-over-year increase in revenue to $2.9million.
Contact Details
Proactive UnitedStates
Proactive United States
+1347-449-0879
Copyright (c) 2023 TheNewswire - All rights reserved.